For over 20 years, IAVI’s Europe hub has been working with partners around the world to build awareness of and support for vaccine and antibody development
This multidisciplinary team brings together colleagues working in advocacy, communications, donor relations, access, epidemiology, project management, and human resources. Together, the team manages programs and partnerships across five different countries plus the European Union (EU) and Europe-based international organizations. IAVI maintains offices in Amsterdam and London.
At a glance
years in Europe
Offices in Amsterdam and London
current European funders
We mobilize European support for global health impact
We work hard to ensure European funders continue to prioritize and invest in vaccine research and development (R&D). Several of IAVI’s most generous and longstanding public sector funders are from Europe, including the governments of the Netherlands (since 1999), Denmark (since 2001), and the European Commission (since 2003), and most recently the government of Germany (since 2023). Together, these donors contribute millions of Euros per year to support global health R&D carried out by IAVI and our partners.
Learn more about IAVI’s fundersWe work with a vibrant network of partners
We engage closely with diverse European stakeholders, including policymakers, scientists, activists, civil society organizations (CSOs), and product development partnerships (PDPs) to ensure that the necessary resources and policies are in place to support global health R&D worldwide.
Our collaborations with our advocacy partners are key to achieving our goals, including CSOs such as AIDS-Fondet (Denmark), AIDS Fonds (Netherlands), Global Health Advocates (France), RESULTS UK, and Deutsche Stiftung Weltbevölkerung (EU and Germany). We’re also a founding member of the EU PDP Coalition, where together with fellow PDPs we advocate for global health R&D at the EU level and in key countries.
IAVI’s Europe hub also manages several important partnerships at the EU level, including the LEAP4WA project to advance a vaccine to prevent Lassa fever in West Africa, and the UPTAKE project, which seeks to determine factors that facilitate future uptake of long-acting HIV prevention technologies to prevent HIV among women and girls in Kenya and Uganda. Past EU partnerships include the Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT) and the European HIV Vaccine Alliance (EHVA).
Collaborate with us
Contact us to learn how to collaborate with us on initiatives at the European level, including in advocacy, resource mobilization, and clinical development.
Hester Kuipers
HKuipers@iavi.org